Arryx, Inc is now a wholly-owned subsidiary of Haemonetics. Arryx Research facilities, personnel, and operations will remain in Chicago. more...
Haemonetics (NYSE: HAE)
is a global healthcare company dedicated to providing
innovative blood management solutions for our customers.
Together, our devices and consumables, information
technology platforms, and consulting services deliver a
suite of business solutions to help our customers improve
clinical outcomes and reduce the cost of healthcare for
blood collectors, hospitals, and patients around the world.
Our technologies address important medical markets: blood
and plasma component collection, the surgical suite, and
hospital transfusion services. To learn more about
Haemonetics, visit our web site at
www.haemonetics.com.
Arryx Technology
Arryx's patented HOT technology uses focused light to form optical traps that function like microscopic "tractor beams" to grab small objects. These optical traps (also known as laser tweezers) can hold, move, rotate, join, separate, stretch, and otherwise manipulate hundreds of microscopic and nanoscopic objects, ranging from the size of a human cell down to less than 1/1000th the diameter of a human hair. Optical Trapping Overview
Arryx's proprietary technology gives rise to multiple applications. Arryx's first product, the BioRyx® 200 optical trapping system, is able to produce and move multiple optical traps for manipulating cells, beads, or other objects. Because our technology can use multiple laser beams at low power to hold an object, it is ideal for handling cells and other sensitive objects and materials. The BioRyx 200 system can be used to collect specified types of cells from a mixed suspension, manipulate cells for enhanced viewing, measure cell-cell interactions and cell-object interactions, and hold sample material for further investigation or isolation. BioRyx 200 application brochure
Arryx has received several awards for innovation. The BioRyx 200 system has been sold to several universities and government institutions, including the National Institute of Standards and Technology. Arryx is now leveraging its technology in developing new products.
For additional scientific and technical information on Arryx's technology, visit Dr. Grier's website at physics.nyu.edu/grierlab/.
Arryx uses "Arryx" and "BioRyx" as trademarks and service marks. All other trademarks, service marks and trade names referred to herein are the property of their respective owners.